Cargando…
Financial Outcomes of “Bagging” Oncology Drugs Among Privately Insured Patients With Cancer
This cohort study examines the difference in per-patient per-month costs between drugs distributed under “bagging,” a drug delivery model that requires patients to obtain physician-administered medications via pharmacies, and traditional buy-and-bill practice.
Autores principales: | Shih, Ya-Chen Tina, Xu, Ying, Yao, James Ching |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485724/ https://www.ncbi.nlm.nih.gov/pubmed/37676663 http://dx.doi.org/10.1001/jamanetworkopen.2023.32643 |
Ejemplares similares
-
Financial Burden of Discarded Weight-based Antineoplastic Drugs to Payers and Patients in the Private Insurance Market
por: Shih, Ya-Chen Tina, et al.
Publicado: (2021) -
Implementation of Shared Decision Making for Lung Cancer Screening Among the Privately Insured Nonelderly
por: Shih, Ya-Chen Tina, et al.
Publicado: (2021) -
Financial Knowledge and Private Health Insurance: Does Age Matter?
por: Aguiar-Díaz, Inmaculada, et al.
Publicado: (2023) -
Antibiotic restriction policy paradoxically increased private drug consumptions outside Taiwan’s National Health Insurance
por: Kuo, Shu-Chen, et al.
Publicado: (2017) -
Private Health Insurance Plans in 1977: Coverage, Enrollment, and Financial Experience
por: Carroll, Marjorie Smith, et al.
Publicado: (1979)